A new melatonin analogue 6-hydroxy-
N-acetyl-β-oxotryptamine (
1) was isolated from the marine-derived fungus
Penicillium sp. KMM 4672. It is the second case of melatonin-related compounds isolation from microfilamentous fungi. The neuroprotective activities of this metabolite, as well as 3-methylorsellinic acid
[...] Read more.
A new melatonin analogue 6-hydroxy-
N-acetyl-β-oxotryptamine (
1) was isolated from the marine-derived fungus
Penicillium sp. KMM 4672. It is the second case of melatonin-related compounds isolation from microfilamentous fungi. The neuroprotective activities of this metabolite, as well as 3-methylorsellinic acid (
2) and 8-methoxy-3,5-dimethylisochroman-6-ol (
3) from
Penicillium sp. KMM 4672, candidusin A (
4) and 4″-dehydroxycandidusin A (
5) from
Aspergillus sp. KMM 4676, and diketopiperazine mactanamide (
6) from
Aspergillus flocculosus, were investigated in the 6-hydroxydopamine (6-OHDA)- and paraquat (PQ)-induced Parkinson’s disease (PD) cell models. All of them protected Neuro2a cells against the damaging influence of 6-OHDA to varying degrees. This effect may be realized via a reactive oxygen species (ROS) scavenging pathway. The new melatonin analogue more effectively protected Neuro2A cells against the 6-OHDA-induced neuronal death, in comparison with melatonin, as well as against the PQ-induced neurotoxicity. Dehydroxylation at C-3″ and C-4″ significantly increased free radical scavenging and neuroprotective activity of candidusin-related
p-terphenyl polyketides in both the 6-OHDA- and PQ-induced PD models.
Full article
